Main > ONCOLOGY (**) > Multiple Myeloma*** > Prognostics *** > Co: NL. S. New Diag>High/Low Risk>

---

Co: NL. S. New Diag>High/Low Risk>'s subsections
(*) EU Approval Date: 2015. 11.25
>Activity of 92 Genes
Company
Patent>Assignee; Claims; No.; Etc.
TradeMark
TradeMark Web-Site

Co: NL. S. New Diag>High/Low Risk>'s products
This section has no products